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Abstract
Although brain injury after neonatal encephalopathy has been characterised well in high-income countries, little is known
about such injury in low- and middle-income countries. Such injury accounts for an estimated 1 million neonatal deaths per
year. We used magnetic resonance (MR) biomarkers to characterise perinatal brain injury, and examined early childhood
outcomes in South India.
Methods: We recruited consecutive term or near term infants with evidence of perinatal asphyxia and a Thompson
encephalopathy score $6 within 6 h of birth, over 6 months. We performed conventional MR imaging, diffusion tensor MR
imaging and thalamic proton MR spectroscopy within 3 weeks of birth. We computed group-wise differences in white
matter fractional anisotropy (FA) using tract based spatial statistics. We allocated Sarnat encephalopathy stage aged 3 days,
and evaluated neurodevelopmental outcomes aged 3K years using Bayley III.
Results: Of the 54 neonates recruited, Sarnat staging was mild in 30 (56%); moderate in 15 (28%) and severe in 6 (11%), with
no encephalopathy in 3 (6%). Six infants died. Of the 48 survivors, 44 had images available for analysis. In these infants,
imaging indicated perinatal rather than established antenatal origins to injury. Abnormalities were frequently observed in
white matter (n = 40, 91%) and cortex (n = 31, 70%) while only 12 (27%) had abnormal basal ganglia/thalami. Reduced white
matter FA was associated with Sarnat stage, deep grey nuclear injury, and MR spectroscopy N-acetylaspartate/choline, but
not early Thompson scores. Outcome data were obtained in 44 infants (81%) with 38 (79%) survivors examined aged 3K
years; of these, 16 (42%) had adverse neurodevelopmental outcomes.
Conclusions: No infants had evidence for established brain lesions, suggesting potentially treatable perinatal origins. White
matter injury was more common than deep brain nuclei injury. Our results support the need for rigorous evaluation of the
efficacy of rescue hypothermic neuroprotection in low- and middle-income countries.
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Introduction
In high-income countries, neonatal encephalopathy occurs in 1
to 3 per 1000 live births; approximately 20 to 25% of the affected
infants die, and 40% of the survivors have significant brain injury
and lifelong disability [1,2]. Magnetic resonance (MR) studies in
the 1990s suggested that the brain injury in these infants is of
perinatal origin, rather than being established antenatally, and is
therefore potentially treatable [3–5]. This suggestion was followed
by a number of randomised controlled trials in high-income
countries, demonstrating a reduction in brain injury, and an
improvement in survival with normal neurological outcomes
following brain cooling therapy [6–9]. Cooling is now offered as
standard of care therapy for neonatal encephalopathy of apparent
hypoxic-ischaemic origin in high-income countries. Cerebral MR
biomarkers, especially elevated proton spectroscopy lactate/N-
acetylaspartate peak-area ratios in deep brain nuclei, and reduced
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white matter water-diffusion fractional anisotropy (FA) correlate
well with adverse neurodevelopmental outcomes in these infants
[10–12].
Approximately 99% of deaths (1 million deaths per year) from
neonatal encephalopathy occur in low- and middle-income
countries [13]. Thus, the global health benefit of cooling therapy
is potentially far higher in low- and middle-income countries than
in high-income. However, there are limited data on the pattern of
brain injury and early childhood outcomes after neonatal
encephalopathy in low- and middle-income countries. Before
cooling therapy is evaluated as a potential treatment in low- and
middle-income countries, it is crucial to understand the origins and
nature of brain injury and early childhood neurodevelopmental
outcomes in these populations.
In this study, we aimed to apply cerebral MR biomarkers to
characterise the nature of brain injury in a cohort of term neonates
with neonatal encephalopathy in South India.
Methods
Ethics Statement
The Government Medical College, Kozhikode Institutional
Review Board and University College London Ethics Committee
approved the study.
Study Design
We prospectively screened for eligibility consecutive newborn
infants admitted to Government Medical College, Kozhikode,
Kerala, India, between July 2009 and December 2009. Infants
requiring resuscitation at birth and/or Apgar score #5 at 5
minutes after birth and a Thompson encephalopathy score .5
[14] within 6 hours after birth, as assessed by a research physician,
were recruited after parental consent. We excluded infants of ,36
gestational weeks and/or of birth weight ,1800 g, and those in
whom a major congenital malformation was evident. Towards the
second half of the study, some infants received whole body cooling
using phase-changing material [15].
We performed infection screening (blood counts, blood culture,
and plasma C–reactive protein) on all infants at admission and at
age 3 days, and intravenous antibiotics were given if clinically
indicated. For the purpose of the study sepsis was defined as
clinical signs of infection as assessed by the attending clinician
along with C-reactive protein .10 mg/l with or without positive
blood culture, and treatment with antibiotics. We also measured
renal and liver function, electrolytes, and coagulation profile soon
after birth and again between 3 and 4 days of age, and blood
glucose levels every 6 hours. An experienced neonatologist (MA)
performed daily Thompson encephalopathy scoring until age 4
days, Sarnat staging [16] at age 3 days and a neurological
examination at discharge [17]; infants were classified as abnormal
if displaying alterations in alertness or tone, or neurological deficits
on the discharge examination.
MR imaging examinations were performed using a 1.5 Tesla
scanner (Siemens Avanto, Erlangen, Germany) between the ages
of 1 to 3 weeks. The scanning protocol included 3D longitudinal
relaxation time (T1)-weighted fast low-angle shot (FLASH),
transverse relaxation time (T2)-weighted 2D fast spin-echo images
(axial and coronal planes), diffusion tensor imaging (DTI; spin-
echo echo-planar imaging sequence, 20 directions, b 0 & 1000 s/
mm2, repetition time (TR)/echo time (TE) 2800 ms/94 ms,
acquisition matrix 1286128, contiguous 5 mm thick axial slices)
and proton MR spectroscopy (water-suppressed point-resolved
spectroscopy (PRESS), TR/TE=2290 ms/288 ms, 3768
summed echo sub-spectra) in a single cubic voxel of
15615615 mm3 positioned in the left thalamus. Total MR
imaging and spectroscopy scan duration was 35 minutes, during
which heart rate and oxygen saturation were continuously
monitored. Ear plugs were used for hearing protection throughout,
and intra-nasal midazolam was administered if sedation was
required.
MR Data Analysis
An experienced perinatal neurologist (FMC) assessed the MR
images according to a validated encephalopathy scoring system,
masked to the clinical details, early childhood outcomes and other
MR biomarker data but aware of the gestational age at birth and
postnatal age at scan [18]. The nature of the brain injury was
further classified to be either antenatal (e.g. cystic lesions, regions
of tissue loss, longstanding haemorrhage, enlargement of ventric-
ular and extra-cerebral spaces) or perinatal (e.g. acute evolving
lesions, loss of cortical grey matter and white matter differentia-
tion, brain swelling) [5]. Evidence for abnormal brain develop-
ment was also assessed.
We analysed whole-brain white matter FA with tract-based
spatial statistics (TBSS) using the Functional Magnetic Resonance
Imaging of the Brain Software Library (FSL, Version 4.1) [19] and
the Diffusion Tensor Imaging ToolKit (DTI-TK, Version 2.3.1)
[20]. First, for each subject, diffusion-weighted data were
corrected for motion and eddy current distortion, segmented to
exclude extracerebral tissue, and used to reconstruct the diffusion
tensor volume, with FSL. Second, the diffusion tensor volumes
from all the subjects were spatially normalised with an optimized
pipeline in DTI-TK. The pipeline uses the state-of-the-art
diffusion tensor image registration algorithm [18] to provide the
optimal alignment of white matter anatomy [21]. Finally, the
spatially-normalised FA volumes were used to perform the TBSS
analysis as previously described [22]. A lower FA threshold (.
0.10) was required to identify the most prominent white matter
tracts. Significance for each test was considered to be the presence
of group-wise FA differences with p,0.05, corrected for multiple
comparisons using Threshold-Free Cluster Enhancement [23].
We analysed MR spectra using the jMRUI spectroscopy
package [24], and sub-spectra with motion artefacts were
corrected or discarded prior to summation. Relative peak-areas
of choline, creatine, lactate and N-acetylaspartate were deter-
mined using the AMARES spectrum fitting algorithm [25].
Early Childhood Outcome Evaluation
An experienced UK and international trainer BH with the
assistance of RS trained the local occupational therapist (JK) and a
clinician (NS) to administer the Bayley III examination [26]. The
parents were contacted by telephone or sent letters, asking them to
attend the outpatient assessments unit at Government Medical
College, Kozhikode between December 2012 and March 2013.
We performed a detailed neurological examination in all infants
to identify cerebral palsy or other neurological deficits, and
administered the Bayley III examination. In addition, we assessed
the functional severity of cerebral palsy using the Gross Motor
Function Classification System (GMFCS) [27], measured head
circumference, height and weight, and assessed hearing and vision.
The assessors were masked to the neonatal MR biomarker findings
and neonatal clinical information, but were aware that the infants
had met the initial recruitment criteria.
Abnormal outcome was classified as cerebral palsy of any
severity, any form of visual (not correctable by glasses) or hearing
impairment; evidence of seizures after the neonatal period and/or
continued use of anti-epileptic medication at age 3K years; slowed
head growth (reduction of .2 standard deviations from head
Neonatal Encephalopathic Injury in South India
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circumference centile at birth assessed using WHO 2006 head
circumference charts, corrected for sex); or a composite motor
score ,82 or composite cognitive score ,85 on Bayley III [28],
allowing for differences in scores between the Bayley II and Bayley
III examinations.
We used exact methods to calculate confidence intervals, and
Chi-square tests and t-tests to examine statistical significance. The
data were analysed using SPSS (Version 21, International Business
Machines Corp, Armonk, New York) and MedCalc (Version
12.7.0, MedCalc Software, Ostend, Belgium).
Results
A total of 11,532 neonates were born at Government Medical
College, Kozhikode during the 6 month recruitment period. Of
these, 164 infants were eligibility screened subject to having a
5 min Apgar score ,6 or requiring bag and mask/endotracheal
tube resuscitation at birth: 54 met the inclusion criteria and were
recruited into the study (Figure 1). Sarnat staging on day 3 showed
mild encephalopathy in 30 infants (56%), moderate encephalop-
athy in 15 (28%) and severe encephalopathy in 6 (11%); 3 infants
(6%) were not encephalopathic by this time. Demographic and
biochemical data are given in Tables S1 and S2); along with blood
pressure oxygen saturation and blood glucose levels (Figure S1).
Four infants had significant hypoglycaemia, defined as a persistent
low blood glucose (,2.6 mmol/l for $12 hours) as shown in
Figure S2. Seventeen of the infants in the latter part of the study
were randomised to cooling.
Thompson scores fell from days 1 to 4 in infants with mild
encephalopathy (mean reduction of 4.7, 95% CI 4.0–5.4), but
score decline was less marked in infants with moderate or severe
encephalopathy (1.1, 20.7–2.8), as shown in Figure S3. The rate
of this decrease was significantly higher in mild encephalopathy
infants compared with moderate/severe infants (mean difference
in reduction 3.6, 21.8–5.5, p,0.001). Six (11%) infants (4 with
severe, 2 with moderate encephalopathy) died before discharge
from hospital. In the remaining 48, neurological examination at
discharge was abnormal in 22 (46%) of whom 8 (36%) had been
cooled.
Thompson scores at age 6 hours poorly identified infants eligible
for cooling as defined by Sarnat encephalopathy stage (moderate
or severe) at age 3 days (Figure S4). Analysis of the receiver
operator characteristic curve yielded an optimal cut-off of .7
(Youden index 0.47). Using this cut off, 28% of neonates
considered eligible for cooling had mild encephalopathy and
22% of ineligible neonates had moderate encephalopathy on later
Sarnat staging.
Conventional MR Imaging
Of the 48 surviving infants, MR imaging was performed in 47 at
mean (standard deviation) age 9.3 (3.6) days. One infant had
computed X-ray tomography imaging only. Unfortunately, the
MR images were lost in 3 cases before reporting and analysis for
the study could be done. All the remaining MR images were of
good enough quality for conventional reporting and without
significant motion artefacts. Fourteen (32%) infants had small
intracranial, mainly posterior fossa subdural bleeds not of long-
term clinical significance.
No infants had evidence of antenatal/established brain injury
on MR imaging, whilst all had some evidence of acute perinatal
Figure 1. Study flow chart.
doi:10.1371/journal.pone.0087874.g001
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brain injury (Table 1). Forty (91%) had white matter injury; with
18 (41%) having mild changes, 16 (36%) moderate and 6 (14%)
severe. Also common was involvement of the cortex, with 31 (70%)
displaying abnormalities, though mostly mild. Only 12 (27%)
infants showed any injury to the basal ganglia and thalami, mostly
mild or moderate, and 5 (11%) displayed absence of the usual high
signal intensity in the posterior limb of the internal capsule (PLIC)
on T1 weighted imaging.
DTI and Thalamic MR Spectroscopy
A total of 31 infants had good quality DTI (including 5 with
slice thicknesses between 5.5–6.5 mm) and 22 had MR spectros-
copy data for analysis. Figure 2 shows the FA reductions according
to conventional MR imaging grades. The proportion of the mean
FA-skeleton voxels with significantly lower FA (p,0.05 and p,
0.01) is shown in each case. Those infants with moderate/severe
encephalopathy had globally reduced FA compared with the rest
of the cohort (Figure 3). The same was seen for those with
Thompson scores .4 at ages 3 and 4 days, but there was no
significant relationship with Thompson score at age 2 days, or with
scores.6 at age 6 hours. No significant FA changes were observed
between cooled and normothermic infants, or between infants
with and without signs of early onset sepsis.
Infants with moderate/severe basal ganglia/thalamic or cortical
injury, or loss of the normal PLIC signal intensity displayed
globally reduced FA compared to those without these findings.
Although moderate/severe white matter injury was also associated
with lower FA, the level of significance was lower (Figure 2).
Twenty-two infants underwent thalamic MR spectroscopy of
whom 20 also had DTI. Using predefined cut-off thresholds [10],
2 of these infants (10%) had elevated lactate/N-acetylaspartate ($
0.29); 2 (10%) had elevated lactate/choline ($0.25) and 3 (15%)
had elevated lactate/creatine ($0.39). Two infants (10%) had
reduced N-acetylaspartate/choline (#0.72), and none had abnor-
mal N-acetylaspartate/creatine (#1.20). Infants with abnormal
N-acetylaspartate/choline had globally lower FA (Figure S5).
There was no significant FA change for other metabolite ratio cut
offs.
Neurological Outcomes at Age 3K years and Relation to
Perinatal and Scan Data
Of the 48 survivors, 38 (79%) were seen for follow up (mean
(standard deviation) assessment age of 3.4 (0.2) years). This
included 24 (63%) with mild, 10 (26%) with moderate and 2 (5%)
with severe neonatal encephalopathy (Table S3).
Abnormal outcome was found in 16 of the 38 infants seen; 3
had cerebral palsy (2 GMFSC level 1 and 1 with GMFCS level 5),
4 had a composite Bayley III cognitive score,85, 1 had abnormal
vision, 9 had a fall in occipital-frontal circumference centile of .2
standard deviations and 3 had an ongoing need for anti-epileptics.
An adverse outcome was found in 8 of 24 (33%) infants with
mild encephalopathy, 5 of 10 (50%) with moderate, and 2 of 2
(100%) with severe encephalopathy (Tables 2 and 3). Two of the
infants with mild encephalopathy who had adverse outcomes (1
with cerebral palsy and 1 with slow head growth) also both had
mild prolonged perinatal hypoglycaemia (Figure S2). There was a
significant FA reduction in neonates with cerebral palsy or low
Bayley III scores compared to the group of neonates with normal
outcomes (Figure 4). There was no significant FA difference in
those with slow head growth compared to this normal outcome
group. MRI scoring was most accurate in the basal ganglia/
thalami and PLIC for identifying poor neurodevelopmental
outcomes at early childhood (Figure S6).
Discussion
Although the nature of brain injury and early childhood
outcomes in neonatal encephalopathy is well studied in high-
income countries, there is very limited data from low and middle-
income countries. In this prospective cohort study from a low and
middle-income country, we report several important observations
Table 1. Brain injury on conventional MR imaging.
Brain Region Visual Interpretation
Normal{/mild neonatal
encephalopathy (n=29{)
Moderate`/severe neonatal
encephalopathy (n =15`)
Posterior limb of the internal capsule 0–Normal signal intensity 23 (79%) 9 (60%)
1–Equivocal signal intensity 4 (14%) 3 (20%)
2–Abnormal signal intensity 2 (7%) 3 (20%)
Basal ganglia and thalami 0–Normal 24 (83%) 8 (53%)
1–Mild injury 2 (7%) 2 (13%)
2–Moderate injury 3 (10%) 4 (27%)
3–Severe injury 0 (0%) 1 (7%)
White matter 0–Normal 4 (14%) 0 (0%)
1–Mild injury 11 (38%) 7 (47%)
2–Moderate injury 12 (41%) 4 (27%)
3–Severe injury 2 (7%) 4 (27%)
Cortex 0–Normal 9 (31%) 4 (27%)
1–Mild injury 15 (52%) 6 (40%)
2–Moderate injury 4 (14%) 3 (20%)
3–Severe injury 1 (3%) 2 (13%)
Values are frequency (% of n).
{Three infants had no encephalopathy on day 3 Sarnat stage.
`13 had moderate encephalopathy.
doi:10.1371/journal.pone.0087874.t001
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in the nature of brain injury that may be useful in developing
neuroprotective strategies for this population. Most infants studied
(91%) had some change in white matter signal on conventional
MR imaging; 41% had mild abnormality, 36% moderate and
14% severe based on a previously validated MR imaging scoring
system [18]. Only 27% had any basal ganglia/thalamic injury and
this was mild or moderate though may have been more severe in
the 6 infants who died but were not imaged. Whole-brain white
matter FA was associated with reduced MR spectroscopy
N-acetylaspartate/choline, cortical and basal ganglia/thalamic
injury and loss of the normal PLIC signal intensity, but not with
visual assessment of white matter injury on conventional MR
imaging. Conversely, the severity of the Thompson encephalop-
athy score at age ,6 hours did not parallel the severity of brain
injury assessed on MRI, nor was it useful in the early identification
of potential candidates (i.e. moderate or severe encephalopathy)
for neuroprotective therapies. However, whole-brain white matter
FA was strongly associated with Sarnat encephalopathy staging.
Figure 2. TBSS analysis of whole-brain white matter FA according to conventional MR imaging abnormalities. In each case FA is
compared between the infants classified abnormal (by the criterion given), and the other infants in the cohort. Red-yellow pixels denote regions of
white matter where FA values are different between groups with p,0.05–p,0.01, green pixels denote regions where p$0.05.
doi:10.1371/journal.pone.0087874.g002
Figure 3. Whole-brain white matter FA according to perinatal clinical assessment. p value maps are displayed as described in Figure 2.
Neuro =neurological; Ther. hypotherm. = therapeutic hypothermia.
doi:10.1371/journal.pone.0087874.g003
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More importantly, the brain injury seen in this prospective cohort
appears to be of perinatal origin, and hence is potentially
amenable to cooling therapy; none of the infants had MRI
evidence of established brain injury clearly preceding the
intrapartum period.
Of the 54 infants recruited, 6 (11%) died before discharge.
Thirty-eight of the remaining 48 infants had early childhood
outcome evaluations. Adverse outcomes were seen in 16/38 (42%)
infants followed until age 3K years. This included 3 (8%) children
with cerebral palsy, 9 (24%) with slow head growth and 4 (11%)
with low scores on the Bayley III assessment [28]. Furthermore, in
infants with mild neonatal encephalopathy, 8 (27%) had adverse
outcomes. Prolonged though mild hypoglycaemia during the first
90 hours after birth was recorded in 2 (25%) of these infants.
The incidence of adverse outcomes at age 3K years after mild
encephalopathy in our study is higher than that reported from
high-income countries, but comparable to data from Nepal [29],
where adverse outcome was reported in 9 (26%) of the 35 infants
with mild encephalopathy followed up to 1 year of age. As no
blood or imaging investigations were performed, the exact cause of
higher incidence of adverse outcomes in infants with mild
encephalopathy was unclear in that study. In addition, we
included slow head growth as an adverse outcome unlike the
previous studies, which might explain our higher rate of
unfavourable outcome. We also chose to use higher Bayley III
cut-offs in comparison to other studies using Bayley II, due to the
apparent discrepancies in normal ranges [28]. We considered slow
head growth with normal Bayley III scores and normal
neurological examination at 3K years as an adverse outcome
due to the potential association of learning difficulties, and other
behavioural problems in infants with slow head growth when
followed up to school age [30,31]. Further follow up of these
infants may be required to examine the relationships between our
findings and intelligence quotient and any behavioural problems.
Our use of tensor-based registration in DTI-TK has minimised
the amount of bias in choosing a representative template for inter-
subject analysis of white matter FA. Where comorbidity groupings
were associated with dramatic FA changes, the tensor-based-
registration method did not necessarily translate into higher
overall t-statistics than when using FA-based registration [32], but
there were noticeable reductions in significance for comparisons
which had yielded borderline significance with the FA-based
method (e.g. thalamic lactate/N-acetylaspartate, white matter
appearance on conventional MR imaging, discharge neurology).
While the TBSS method incorporates a correction for multiple
voxel-wise comparisons within each group-wise test (‘threshold-
free cluster enhancement [21]’), the range of tests performed was
for exploratory analysis, and so should be interpreted with care
due to the reduced significance of each result. Each test we
performed has therefore been included to ensure transparency.
The high incidence of white matter abnormality seen on MRI
scan in this cohort is in sharp contrast to the predominantly basal
ganglia/thalamic pattern of lesions seen in high-income countries,
which are highly associated with poor outcomes [18,33–35]. This
difference in injury pattern may be somewhat exaggerated since 6
infants died before MR imaging, and in these more severe cases
basal ganglia/thalamic injury is often seen. Strong association of
whole brain white matter FA with thalamic N-acetylaspartate/
choline, a marker of cell membrane injury, indicates a close
relationship between thalamic metabolic perturbations and white
matter microstructure. Given this, the relatively weak dependence
of white matter FA on white matter MR imaging appearance was
unexpected, and suggests that visual MR imaging interpretation of
this injury may be subjective or transient – however most of the
Table 3. Early childhood outcomes of infants according to Sarnat neonatal encephalopathy staging.
Outcome
Mild encephalopathy
(n=24)
Moderate encephalopathy
(n =12) Severe encephalopathy (n=6)
Died 0 (0%) 2 (17%) 4 (67%)
Survival with normal outcome* at 3K years 16 (67%) 5 (42%) 0 (0%)
Values are frequency (% of n);
*Normal outcome defined as Bayley III cognitive score$85 and motor composite score $82; with normal head growth; normal neurological examination; normal vision
and hearing; and no ongoing seizures at 3K years.
doi:10.1371/journal.pone.0087874.t003
Figure 4. Whole-brain white matter FA according to outcome assessment aged 3K years. p value maps are displayed as described in
Figure 2, only using those with 3K year outcome data for group-wise comparisons. Low Bayley III = infants with scores below predefined cut-offs for
Bayley III (,82 for composite motor score, ,85 for composite cognitive score); Slow head growth= isolated slow head growth (fall in head
circumference centile from birth to follow-up of .2 standard deviations), with otherwise normal neurological examination and Bayley III scores.
doi:10.1371/journal.pone.0087874.g004
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white matter change seen in this group was mild or moderate and
been shown in studies of encephalopathy in high-income countries
to be associated with good outcomes [35]. The dependence on
basal ganglia/thalamic injury agrees with others [18,34,35] who
associated such a relationship with poorer neurodevelopmental
outcomes. Indeed, 18 of 33 (55%) infants with white matter injury
and follow-up data went on to have normal outcomes at age 3K
years; in contrast to the 4 of 11 (36%) infants with any basal
ganglia/thalami injury who had normal outcomes. Although we
collected composite language scores in the Bayley III assessment,
these were not analysed due to the subjectivity of their non-English
application. Since the assessment was performed close to the upper
age range for Bayley III, our results may suffer from a ‘ceiling
effect’ but it is unlikely that children would fall below a score of 85
for this reason.
Given the increasing understanding of longer-term neurodevel-
opment problems arising from perinatal white matter injury, such
abnormalities may not be apparent at early follow-up, in
agreement with the findings of de Vries and others [36,37]. This
would also explain the poor agreement between FA and the
neurological discharge examination.
Within 6 hours of birth, Thompson scores [14] are poor at
identifying infants eligible for cooling, as illustrated in the
Supporting Information (Figure S4), and we suggest should not
be used for this purpose. As the cut-off score increases, fewer
neonates with mild neonatal encephalopathy would be chosen for
cooling but more moderate/severe cases would be considered
ineligible. Even at a score cut-off of 9, 10% of the cooled neonates
would have mild neonatal encephalopathy, and 27% of uncooled
neonates would have moderate/severe encephalopathy as judged
by the day 3 Sarnat score. This is reinforced by the lack of FA
change when assessing the cohort according to Thompson score
within the first 2 days after birth. This may be due to the non-
physiological allocation of equal score to any abnormality in the
Thompson score, as opposed to more physiological categorisation
used in the recently validated NICHD encephalopathy scoring
system [38], and hence the latter may be a better clinical criterion
for identifying potential candidates for cooling.
No significant white matter microstructural changes were
associated with therapeutic hypothermia. This observation is not
entirely unexpected, as the study was not intended to examine the
therapeutic effect of hypothermia and the infants who received
cooling were not adequately matched with normothermic infants
in terms of other clinical morbidities, as would be the case in a
randomised controlled trial (Table S4). Nevertheless, adequately
powered clinical trials would be required to evaluate cooling in
low- and middle-income countries, as it remains unclear whether
cooling therapy would be have a similar safety and efficacy profile
outside the setting of a high-income country tertiary neonatal
intensive care unit [39]. As a tentative guide for future studies, the
specificity and sensitivity of MRI in identifying adverse outcomes
in this cohort is given in Supporting Information (Table S5).
Our study is limited by the absence of a sufficient control group,
as white matter microstructural changes have been compared
between sub-groups of the same cohort. We were unable to image
infants who died early hence the imaging patterns described are
limited to surviving infants. In addition, we were unable to acquire
follow-up data on 19% of the infants; hence, we were limited in
examining the overall neurodevelopment of the cohort. As the
early childhood follow-up was originally unfunded, we were
unable to maintain regular contact with the families after hospital
discharge, and could only contact the parents if their contact
details were unchanged. All the parents contacted attended follow-
up assessments and it is likely that high follow-up rates can be
obtained if regular family contact is maintained in future studies.
Reassuringly, no systematic differences were seen in the clinical
characteristics or brain injury in the infants lost to follow-up, and
those who attended 3K year follow-up, suggesting the outcome
data may be generalised to the whole cohort.
Due to the lack of available data on the application of MRS in
this population, we have applied cut-off values derived from
studies in high income countries. By applying the same acquisition
scheme as used in the UK, we have minimised the effect of any
systematic differences in protocol. However, it may be the case
that altered cut-off values may identify adverse outcomes more
optimally in this setting.
The strength of the study is in the use of a combination of novel
MR biomarkers to uniquely describe different facets of brain
injury in this population. The advantage of TBSS is its ability to
detect significant white matter microstructural differences even
between small groups, enabling meaningful inferences with limited
numbers of subjects. In addition, the bias in using a standard ‘most
representative subject’ template in TBSS has been overcome by
adapting standard post-processing techniques with DTI-TK
[40,41].
In summary, the population co-morbidities, patterns of brain
injury and early childhood outcomes in neonatal encephalopathy
in this low- and middle-income country cohort have important
characteristics. White matter injury was common, though mainly
mild, although injury to the basal ganglia and thalami, even
though only mild or moderate, was most predictive of abnormal
neurological outcomes. White matter microstructural abnormality
on TBSS was most significantly associated with injury to the basal
ganglia and thalami, thalamic N-acetylaspartate/choline and with
Sarnat staged encephalopathy severity but not with early
Thompson encephalopathy score. Finally, the lack of established
brain injury in this cohort indicated that lesions were likely of
perinatal in origin, and therefore potentially treatable. These data
support rigorous evaluation of rescue hypothermic neuroprotec-
tion in low- and middle-income countries in clinical trials.
Supporting Information
Figure S1 Blood glucose, oxygen saturation (SaO2) and
blood pressure (mean and standard deviation error bar)
in all infants in the first 4 days after birth. Norm/
Mild = normal/mild Sarnat encephalopathy stage at 3 days after
birth; Mod/Sev=moderate/severe Sarnat encephalopathy stage
at 3 days after birth.
(TIF)
Figure S2 Individual blood glucose measurements in
the 4 hypoglycaemic infants in the first 4 days after birth
according to 3K year outcome (Unknown=unpresented
for 3K year assessment).
(TIF)
Figure S3 Mean (standard deviation) Thompson scores
at ages up to 4 days in infants grouped according to
Sarnat neonatal encephalopathy (NE) stage assessed at 3
days after birth.
(TIF)
Figure S4 Use of the 6-hour Thompson score as an
inclusion criterion for cooling therapy compared to the
Sarnat encephalopathy stage (normal, mild, moderate
or severe) at 3 days after birth. Sensitivity and specificity:
infants with moderate/severe Sarnat stage treated as disease
positive, normal/mild stage as disease negative.
(TIF)
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Figure S5 Whole-brain white matter FA according to
MR spectroscopy assessment. p value maps are displayed as
described in Figure 2, only using those with MR spectroscopy data
for group-wise comparisons. NAA=N-acetylaspartate; Lac= lac-
tate; Cho= choline-containing compounds; Cr= total creatine.
(TIF)
Figure S6 Conventional MR imaging (MRI) scores
across infants with different 3K year outcomes. The
solid horizontal line indicates median score for each group.
T= thalami; BG=basal ganglia; CP= infants with cerebral palsy;
Low BIII = infants with scores below predefined cut-offs for Bayley
III (,82 for composite motor score, ,85 for composite cognitive
score); Slow HG= isolated slow head growth (fall in head
circumference centile from birth to follow-up of .2 standard
deviations) with otherwise normal neurological examination and
Bayley III scores; Normal = infants with normal outcome at
follow-up.
(TIF)
Table S1 Clinical characteristics. Values are mean (stan-
dard deviation) or proportion (%) unless otherwise indicated.
{Clinical sepsis with elevated C-reactive protein with or without
positive blood culture, requiring antibiotic treatment, within three
days of birth; CI = confidence interval. *Indicates difference
between groups with p,0.05.
(DOCX)
Table S2 Biochemical characteristics. Values are mean
(standard deviation) unless otherwise indicated. {Denotes skewed
distributions where median (IQR) is reported, along with the
difference in medians (p value of Mann-Whitney U test).
*Indicates difference between group means with p,0.05.
CI = confidence interval; WBC=white blood cells; SGPT= serum
glutamic-pyruvic transaminase; PT=prothrombin time; APT-
T= activated partial thromboplastin time.
(DOCX)
Table S3 Clinical features and brain injury of surviving
infants who attended 3K year follow-up or were lost to
follow-up. Values are proportion (%) unless otherwise indicated.
CI = confidence interval; WM=white matter; BGT=basal gan-
glia and thalami; PLIC=posterior limb of the internal capsule.
(DOCX)
Table S4 Characteristics and outcomes of neonatal
encephalopathy for infants undergoing whole-body
therapeutic hypothermia or normothermia. Values are
mean (standard deviation) or proportion (%). {Sepsis = Clinical
sepsis with elevated C-reactive protein with or without positive
blood culture within three days of birth. {Abnormal outcome= -
cerebral palsy; visual or hearing impairment; evidence of seizures
or use of anti-epileptic medication at age 3K years; slowed head
growth; or a composite motor score ,82 or composite cognitive
score ,85 on Bayley III.
(DOCX)
Table S5 Sensitivity and specificity of conventional MR
imaging in identifying infants with cerebral palsy or low
Bayley III scores (,82 for composite motor, ,85 for
composite cognitive) at 3K years.
(DOCX)
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